Reasons for non-completion of health related quality of life evaluations in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.
<h4>Background</h4>Health related quality of life (HRQL) assessments during therapy for pediatric cancer are important. The objective of this study was to describe reasons for failure to provide HRQL assessments during a pediatric acute myeloid leukemia (AML) clinical trial.<h4>Met...
Guardado en:
Autores principales: | Donna L Johnston, Rajaram Nagarajan, Mae Caparas, Fiona Schulte, Patricia Cullen, Richard Aplenc, Lillian Sung |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d191dbffc6094f1e9ec3f186b8de9d18 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
NEW ADVANCES IN PEDIATRIC ACUTE MYELOID LEUKEMIA
por: Özlem Tüfekçi
Publicado: (2021) -
PONATINIB EXPERIENCE IN A PEDIATRIC CHRONIC MYELOID LEUKEMIA PATIENT
por: Serap Karaman, et al.
Publicado: (2021) -
Pediatric hematology and oncology
Publicado: (1986) -
Peptidomimetic blockade of MYB in acute myeloid leukemia
por: Kavitha Ramaswamy, et al.
Publicado: (2018) -
Treatment outcomes of pediatric acute myeloid leukemia: a retrospective analysis from 1996 to 2019 in Taiwan
por: Yung-Li Yang, et al.
Publicado: (2021)